DRKS00010725
Active, not recruiting
Not Applicable
on-interventional study to observe skin toxicities under a Docetaxel therapy in treatment of concomitant use of Lipikar Baume AP + ® (NIS LipiDoc) - NIS LipiDoc
ORCA2 GmbH0 sites30 target enrollmentJuly 18, 2016
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- L99.8
- Sponsor
- ORCA2 GmbH
- Enrollment
- 30
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Presence of an indication for docetaxel \- containing infusion therapy according to the monitoring plan
- •\- Age \= 18
- •\- Presentation of written consent of the patient data capture
Exclusion Criteria
- •\- Pregnancy, lactation
- •\- Patients with a docetaxel \- intolerance
- •\- Patients with an intolerance of Lipikar Baume AP \+ ® \- application
- •\- Patients in 3rd\- or xth\-line therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To check skin irritation of B JAIN PHARMACEUTICALS multiple skin care productsCTRI/2024/06/068643B Jain Pharmaceuticals Private
Not yet recruiting
Not Applicable
To check Skin irritation potential Ogardener India Multiple Floral waterCTRI/2024/07/070504Ogardener India Pvt Ltd
Not yet recruiting
Not Applicable
Skin irritation potential of Sri Sri Tattva Shankara Mineral SunshieldCTRI/2024/07/070443Sri Sri Tattva Pvt Ltd
Recruiting
Not Applicable
The skin irritation test of Bathing BarCTRI/2024/02/062975HIM CORP
Not yet recruiting
Not Applicable
safety study of Maxnova Biowallice Face SerumCTRI/2024/07/071514Maxnova Healthcare